Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Medico Corporation is a China-based traditional Chinese medicine company focused on the standardized cultivation of Chinese herbal medicines and the production and commercial sale of crude drugs and herbal decoction pieces. The business was formerly known as Tianjin China Medico Technology Co., Ltd. and appears to operate under the Shengshi Baicao name. Its operations span herb cultivation bases, processing, quality control, testing, and export-oriented manufacturing, with products including more than 100 bulk herbal medicines and more than 300 decoction-piece products. The company has collaborated with Tsumura on crude drug sourcing, cultivation, processing, and quality management, and was later acquired by a Ping An/Tsumura-related buyer structure. It is not a drug-development biotech with a disclosed clinical pipeline; rather, it is a commercial-stage traditional Chinese medicine manufacturing and supply-chain company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Medico Corporation.